论文部分内容阅读
杜丁胺(Dobutamine)是一种新的儿茶酚胺,在动物实验中,已证实它几乎是一种单纯心肌收缩剂,对血管的直接作用很小。本文报导Dobutamine临床应用的初步效果。病例与方法:共观察14例,男8,女6,年龄24～74岁。均有继发于心肌病、冠状动脉疾病或瓣膜疾病的心力衰竭。根据心脏功能和心脏指数将病人分成2组。A组4例心功能Ⅱ级,临床上为“代偿期”,
Dobutamine, a new catecholamine, has been shown in animal experiments to be almost a simple myocardial contractile agent with little direct effect on blood vessels. This article reports the initial clinical effect of Dobutamine. Cases and Methods: A total of 14 cases observed, male 8, female 6, aged 24 to 74 years. All have heart failure secondary to cardiomyopathy, coronary artery disease or valvular disease. Patients were divided into two groups based on cardiac function and cardiac index. A group of 4 patients with cardiac function grade Ⅱ, clinically “compensatory phase”